skip to Main Content

Helping You Navigate Centralized Provincial Research Ethics Boards (REBs)

With privileged site relationships across Canada, we rapidly identify the key centers to help you exceed your pivotal corporate milestones- First Site Opened and First Patient In for your phase I, II and III oncology clinical trials.

Many Canadian oncology clinical sites use a Province-wide Multicenter approval process, otherwise known as a Provincial Research Ethics Board (REB). This process is highly efficient yet complex.

It requires drug developers to skillfully identify a “lead site” responsible for coordinating REB approval with all other participating sites.” The REB turn-around time is highly dependent on this.  For this reason alone, it is critical to have the right team on the ground to help you navigate the system and accelerate study start-up.

 Scimega managed to expedite EC/IRB regulatory submissions at the site level, and did it much faster than our global CRO.

- VP Clinical & Medical Affairs -


See how our Ethics Review strategies will speed up REB review and approval of your protocol.

Back To Top
×Close search